Common Variable Immunodeficiency and Other Immunodeficiency Syndromes in Bronchiectasis.
1Section of Pulmonary and Critical Care Medicine, University of Texas Health Science Center at Tyler, Tyler, Texas.
Seminars in Respiratory and Critical Care Medicine
|July 14, 2021
Summary
Immunodeficiency, both primary and secondary, contributes to bronchiectasis development. Early recognition of specific immune deficiencies like CVID and XLA in bronchiectasis patients is crucial for improved care.
Area of Science:
- Pulmonology
- Immunology
- Genetics
Background:
- Immunodeficiency encompasses numerous diseases, significantly contributing to bronchiectasis.
- Both primary (genetic) and secondary (acquired) immunodeficiencies are implicated in bronchiectasis pathogenesis.
- Primary immune deficiencies are increasingly recognized as key factors in bronchiectasis development.
Purpose of the Study:
- To review primary and secondary immunodeficiencies associated with bronchiectasis.
- To highlight specific immune deficiencies linked to bronchiectasis.
- To emphasize the importance of recognizing immunodeficiency in idiopathic bronchiectasis.
Main Methods:
- Literature review of primary and secondary immunodeficiencies and their link to bronchiectasis.
- Discussion of specific primary immunodeficiencies: CVID, SAD, IgE deficiencies, DOCK8, PGM3, APDS, and XLA.
- Examination of secondary immunodeficiencies: GVHD, malignancy, and HIV.
Main Results:
- Several primary immune deficiencies, including CVID, SAD, IgE deficiencies, DOCK8, PGM3, APDS, and XLA, are closely associated with bronchiectasis.
- Secondary immunodeficiencies such as GVHD, malignancy, and HIV can also lead to bronchiectasis.
- Unique clinical presentations of these deficiencies necessitate vigilant recognition in bronchiectasis patients.
Conclusions:
- Improved recognition of specific immunodeficiencies in patients with idiopathic bronchiectasis is essential.
- Awareness of secondary immunodeficiencies is vital for optimizing patient care.
- Understanding the intricate relationship between bronchiectasis and immunodeficiency can elucidate underlying pathophysiology.
More Related Videos
Related Concept Videos
Immunodeficiency Diseases
1.3K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
1.3K
Other Pulmonary Disorders
1.0K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.0K
Pulmonary Tuberculosis I
434
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
434
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.0K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.0K
COPD: Management Using Bronchodilators and Corticosteroids
498
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
498
Chronic Obstructive Pulmonary Disease
1.7K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.7K


